Synageva BioPharma's P2P Acquisition

Synageva BioPharma raised a round of funding on May 06, 2015. Investors include Alexion Pharmaceuticals.

Synageva BioPharma is dedicated to discovering, developing and delivering medicines for patients with rare diseases and unmet medical need. The Company has developed a pipeline of therapeutic products…

Articles about Synageva BioPharma's P2P Acquisition: